Pain Management After Surgery

3

Review clinical trials related to Pain Management After Surgery. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Open TAP-block in Pediatric Abdominal Surgery

The goal of this trial is to evaluate an open TAP-block vs continuous administration of local anestetic via a wound catheter for postoperative pain management in patients 1-15 years of age undergoing open abdominal surgery.

Participants needed: 88
Trial details
Age: 1-15Biological sex: AllType: InterventionalSponsor: Uppsala UniversityUpdated: Jan 20, 2026Locations: 1
Eligibility criteria

Age 1-15 years [+1]

chronic abdominal pain [+3]

Status: Recruiting

The Effect of Intraoperative Intravenous Lidocaine Infusion on Postoperative Pain and Recovery in Children (< 7 Years Old) Undergoing Thoracoscopic Surgery

This study aims to investigate the efficacy of intraoperative intravenous lidocaine infusion on postoperative pain management and recovery in pediatric patients undergoing thoracoscopic pulmonary resection.

Participants needed: 80
Trial details
Phase: Phase 4Age: 6-7Biological sex: AllType: InterventionalSponsor: Seoul National University HospitalUpdated: May 14, 2025Locations: 1
Eligibility criteria

Pediatric patients aged under 7 years undergoing thoracoscopic pulmonary resecti...

cardiac dysfunction requiring vasopressors or inotropic agents [+3]

Status: Not yet recruiting

Post-c-section Pain Control Satisfaction with Erector Spinae Simple Block Vs Lateral Quadratus Lumborum Block

The study will compare the difference between the patient's satisfaction after Erector spinae plane block (ESP) and Quadratus Lumborum block lateral approach after caesarean section alone or as part of multimodal analgesia. The primary outcome is to test whether the type of plane block has an implication on the patients' satisfaction. The secondary outcome is to test the difference between the two approaches on the hospital discharge

Participants needed: 126
Trial details
Age: Up to 40Biological sex: FemaleType: InterventionalSponsor: Wael Sayed El GharabawyUpdated: Jan 13, 2025Locations: 1
Eligibility criteria

Parturient female [+1]

Known allergy to any of the medications used [+4]